Socioeconomic disparities in chronic kidney disease: a systematic review and meta-analysis

P Vart, RT Gansevoort, MM Joosten, U Bültmann… - American journal of …, 2015 - Elsevier
… GFR, p=0.63; high albuminuria, p=0.29; low eGFR/high albuminuria, p=0.54; renal failure,
p=… to the level of covariate adjustment for low eGFR (p<0.001) and high albuminuria (p<0.001). …

COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration

LB Hilbrands, R Duivenvoorden, P Vart… - Nephrology Dialysis …, 2020 - academic.oup.com
P-value <0.1 were entered in this model. The least significant variables were removed stepwise,
until none met the criterion of P… which the association with mortality had a P-value <0.05. …

[HTML][HTML] Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population

F Imtiaz, K Shafique, SS Mirza, Z Ayoob, P Vart… - International archives of …, 2012 - Springer
Preliminary evidence has suggested the role of inflammation in development and prognosis
of cardiovascular diseases and cancers. Most of the prognostic studies failed to account for …

[HTML][HTML] Effects of dapagliflozin in stage 4 chronic kidney disease

GM Chertow, P Vart, N Jongs, RD Toto… - Journal of the …, 2021 - journals.lww.com
… We considered P values <0.05 to be statistically significant. … 2/3 CKD, there were no significant
differences (interaction P values for treatment assignment by CKD stage 0.22, 0.13, 0.63, …

[HTML][HTML] Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA …

…, VJCH Koomen, SRK Malahe, P Vart… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …

COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study

E Goffin, A Candellier, P Vart, M Noordzij… - Nephrology Dialysis …, 2021 - academic.oup.com
… % versus 11.3%; P = 0.30) and obesity (13.0% versus 16.5%; P = 0.06) … ; P = 0.004) and
duration of kidney disease was missing more often in transplant recipients (2.5% versus 8.9%; P

[HTML][HTML] The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on …

…, EBM Remmerswaal, N Rots, P Vart… - …, 2022 - journals.lww.com
… Variables with a P of <0.1 in univariable analysis were … manner, until none met the criterion
of P > 0.1. Missing data were handled on … A 2-sided P < 0.05 was adopted to denote statistical …

Efficacy and safety of dapagliflozin by baseline glycemic status: a prespecified analysis from the DAPA-CKD trial

F Persson, P Rossing, P Vart, GM Chertow… - Diabetes …, 2021 - Am Diabetes Assoc
… The effect of dapagliflozin on the primary outcome was consistent (P for interaction = 0.19)
in normoglycemia (hazard ratio [HR] 0.62 [95% CI 0.39, 1.01]), prediabetes (HR 0.37 [0.21, …

[HTML][HTML] Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

SW Waijer, P Vart, DZI Cherney, GM Chertow, N Jongs… - Diabetologia, 2022 - Springer
… We considered p values <0.05 to be statistically significant, and all analyses were
performed using Stata version 14.2 (StataCorp, USA) or R version 4.0.2 (R Foundation). …

Timing of cardiac surgery during pregnancy: a patient-level meta-analysis

…, QHY Tsang, OWH van der Heijden, P Vart… - European Heart …, 2022 - academic.oup.com
… trimesters of pregnancy (P = 0.292) nor between subgroup CaeSe and CarSu (P = 0.671). …
surgery was performed during the third trimester (10.3%, P < 0.01). CS prior to surgery was …